1101136-50-8 Usage
Uses
Used in Pharmaceutical Industry:
CAY10590 is used as a therapeutic agent for the treatment of various diseases, including cancer, inflammation, and autoimmune diseases. Its ability to modulate S1P signaling pathways allows for the development of targeted therapies that can potentially improve patient outcomes.
Used in Research Applications:
CAY10590 is used as a research tool to study the role of S1P in various biological processes. It is employed in cell migration and proliferation assays, as well as in the investigation of immune responses and angiogenesis. This helps researchers understand the underlying mechanisms of S1P signaling and its implications in disease development.
Used in Drug Delivery Systems:
CAY10590 is used in the development of drug delivery systems to improve the efficacy and bioavailability of therapeutic agents. By incorporating CAY10590 into these systems, researchers can potentially enhance the delivery of drugs to target cells and tissues, leading to more effective treatments for various diseases.
Used in Diagnostic Applications:
CAY10590 can be used as a diagnostic marker to assess the status of S1P signaling pathways in patients. This can help in the early detection of diseases such as cancer, inflammation, and autoimmune disorders, allowing for timely intervention and treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 1101136-50-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,1,1,3 and 6 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1101136-50:
(9*1)+(8*1)+(7*0)+(6*1)+(5*1)+(4*3)+(3*6)+(2*5)+(1*0)=68
68 % 10 = 8
So 1101136-50-8 is a valid CAS Registry Number.
1101136-50-8Relevant academic research and scientific papers
AMIDES AS INHIBITORS OF HUMAN SECRETED PHOSPHOLIPASE A2
-
Page/Page column 7; 8, (2010/04/03)
Methods and compounds useful for inhibiting a phoshpolipase A2 are provided, the methods comprising contacting the phoshpolipase A2 with a compound having the structure A, or pharmaceutically acceptable salts thereof: wherein R1
Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A2 enzymes
Antonopoulou, Georgia,Barbayianni, Efrosini,Magrioti, Victoria,Cotton, Naomi,Stephens, Daren,Constantinou-Kokotou, Violetta,Dennis, Edward A.,Kokotos, George
experimental part, p. 10257 - 10269 (2009/04/12)
A variety of 2-oxoamides and related amides based on natural and non-natural amino acids were synthesized. Their activity on two human intracellular phospholipases (GIVA cPLA2 and GVIA iPLA2) and one human secretory phospholipase (GV
